UnicoCell has been focusing on the development and application of new stem cell drugs for more than 10 years. The company has also been certified by the Ministry of Health and Welfare of Taiwan's GTP laboratory, Japan's PMDA overseas cell processing center, ISO 17025 laboratory, and Human organ bank.
With the same high standard of quality systems required by clinical trials, UnicoCell has partnered with major hospitals in Taiwan on autologous stem cell therapy for knee osteoarthritis.
UnicoCell has partnered with major hospitals in Taiwan to offer autologous stem cell therapy option for patients suffering from knee pain. For more information, please contact email@example.com